The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

Please provide your email address to receive an email when new articles are posted on . Sozinibercept, a VEGF-C and -D “trap” inhibitor, showed improved durability in patients with retinal diseases ...

Individuals in Taiwan who suffer from migraine were at an increased risk of developing neovascular age-related macular degeneration. Individuals suffering from migraine have a 20% increased risk of ...

—The findings about the diagnostic accuracy of the Amsler grid test for early detection of neovascular age-related macular degeneration suggest that the procedure will not replace regular ophthalmic ...

People who take the oral biguanide metformin have a 5% lower odds of developing age-related macular degeneration (AMD) than people who do not use the diabetes drug. The study included 86,930 patients ...

Please provide your email address to receive an email when new articles are posted on . ROME — A deep learning algorithm developed at University of California, Los Angeles, showed superior performance ...

Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The paper-based KeepSight Journal from ...

Detailed price information for Kalaris Therapeutics Inc (KLRS-Q) from The Globe and Mail including charting and trades.

A recent review found that the performance of the Amsler grid test was not at a level that was recommended for detecting early or dry age-related macular degeneration (AMD). Age-related macular ...